Iqvia Holdings IQV
NYSE IQV
$269.47 +0.65 (+0.24%)
As of: Sep 17, 2026 · 3:59 PM EDT

Iqvia Holdings (IQV) EBITDA Margin (QoQ) (2012 - 2026)

Analysis

Iqvia Holdings (IQV) EBITDA Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -80.00
Mar 31, 2026 -198.00
Dec 31, 2025 88.00
Sep 30, 2025 89.00
Jun 30, 2025 -36.00
Mar 31, 2025 -286.00
Dec 31, 2024 170.00
Sep 30, 2024 48.00
Jun 30, 2024 9.00
Mar 31, 2024 59.00
Dec 31, 2023 8.00
Sep 30, 2023 -118.00
Jun 30, 2023 116.00
Mar 31, 2023 276.00
Dec 31, 2022 -311.00
Sep 30, 2022 46.00
Jun 30, 2022 -108.00
Mar 31, 2022 114.00
Dec 31, 2021 383.00
Sep 30, 2021 59.00